GeneDx
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $95,640 | $76,874 | $70,514 | $62,422 |
Gross Profit | 66,205 | 47,829 | 38,542 | 32,979 |
EBITDA | 8,806 | -1,851 | -22,951 | -14,076 |
EBIT | -7,780 | -28,469 | -19,724 | |
Net Income | 5,438 | -8,312 | -29,173 | -20,239 |
Net Change In Cash | 95,640 | 76,874 | 70,514 | 62,422 |
Free Cash Flow | -6,233 | -5,041 | -5,857 | -16,856 |
Cash | 85,212 | 57,894 | 56,076 | 83,673 |
Basic Shares | 26,993 | 27,095 | 26,617 | 26,062 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $305,450 | $202,566 | $234,694 | $212,195 |
Gross Profit | 194,397 | 60,622 | -26,750 | -16,602 |
EBITDA | -23,213 | -136,460 | -398,198 | -219,193 |
EBIT | -170,194 | -461,232 | -242,555 | |
Net Income | -52,286 | -175,767 | -548,980 | -245,390 |
Net Change In Cash | 305,450 | 202,566 | 234,694 | 212,195 |
Free Cash Flow | -33,987 | -185,858 | -333,477 | -211,220 |
Cash | 85,212 | 99,681 | 123,933 | 400,569 |
Basic Shares | 26,891 | 24,311 | 10,236 | 3,275 |
